Skip to main content

Table 1 Correlation of histology markers with survival

From: Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

Treatment arm Parametric survival Weibull p
Necrosis HIF-1α perinecrotic area HIF-1α vital tumor P-PRAS40 P-RPS6 Iba1
Nimotuzumab 0.7360 0.3733 0.6135 0.2365 0.6078 0.5149
Control 0.1003 0.4436 0.7257 0.6929 0.2967 0.0275
  1. Univariate Weibull parametric survival analysis was performed for the listed parameters